semaglutide salts FDA warns about compounded versions of semaglutide, used for diabetes, weight loss Clark - We are so

A monomolecular coagonist (tirzepatide) of receptors for both incretin hormones (glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide) produced HbA1c values below 5.7% in 50% of the treated patients and weight losses exceeding 20% in obese individuals

doi:10.3892/mmr.2017.6321 10

Bupropion does not typically cause temperature sensitivity, but the stimulant-like properties can cause sweating in some users, creating a confusing situation where someone feels cold from tirzepatide weight loss but sweats from bupropion norepinephrine activity

doi: 10.2337/diabetes.52.1.124 [DOI] [PubMed] [Google Scholar] 20

Patients on tirzepatide were 1.8 more likely to achieve 5% weight loss, 2.6 more likely to achieve 10%, and 3.2 more likely to achieve 15% weight loss compared to semaglutide